Analysis of Prostate Cancer Tumor Microenvironment Identifies Reduced Stromal CD4 Effector T-cell Infiltration in Tumors with Pelvic Nodal Metastasis
Open Access
- 25 May 2021
- journal article
- research article
- Published by Elsevier BV in European Urology Open Science
- Vol. 29, 19-29
- https://doi.org/10.1016/j.euros.2021.05.001
Abstract
No abstract availableFunding Information
- Cancer Research UK (A17196, A19661, A22904, A23983)
- Cancer Research UK Beatson Institute (A17196, A19661, A22904, A23983)
This publication has 31 references indexed in Scilit:
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- The immune contexture in human tumours: impact on clinical outcomeNature Reviews Cancer, 2012
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumorsJCI Insight, 2012
- The extracellular matrix: A dynamic niche in cancer progressionThe Journal of cell biology, 2012
- Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive CoresEuropean Urology, 2011
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer PatientsClinical Cancer Research, 2011
- TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by ProstatectomyCancer Research, 2009
- Simultaneous Visualization of Multiple Antigens with Tyramide Signal Amplification using Antibodies from the same SpeciesJournal of Histochemistry & Cytochemistry, 2007
- TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohortOncogene, 2007
- Helping the CD8+ T-cell responseNature Reviews Immunology, 2004